Reasons for Monitoring Kinetics in Safety Evaluation Studies-Reference-Cited by-同舟云学术

Reasons for Monitoring Kinetics in Safety Evaluation Studies

Published:1985 Issue: Volume: Page:165-172
ISSN:0171-9750
Container-title:Archives of Toxicology
language:
Short-container-title:

Author:

Hawkins D. R.,Chasseaud L. F.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-69928-3_26.pdf

Reference7 articles.

1. Down WH, Hawkins DR, Chasseaud LF (1982) Effect of the triazolobenzodiazepine estazolam on hepatic drug-metabolising enzyme activity in rats. J Pharm Pharmacol 34: 432–437.

2. Kaplan SA (1972) Biopharmaceutical considerations in drug formulation design and evaluation. Drug Metab Rev 1: 15–34.

3. Kaplan SA, Jack ML (1980) Pharmacokinetics as a tool in drug development. Progress in Drug Metabolism (J. W. Bridges and L. F. Chasseaud, eds.), vol. 4, pp. 1–55, Wiley, Chichester.

4. Mitchell JR, Jollow DJ (1975) Metabolic activation of drugs to toxic substances. Gastroenterology 68: 392–410.

5. Smyth RD, Hottendorf GH (1980) Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies. Toxicol Appl Pharmacol 53: 179–195.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Telemetry in Nonclinical Drug Safety Assessment Studies;Animal Models in Toxicology;2016-04-05

2. Application of toxicokinetics to improve chemical risk assessment: Implications for the use of animals;Regulatory Toxicology and Pharmacology;2009-12

3. The Acquisition and Application of Absorption, Distribution, Metabolism, and Excretion (ADME) Data in Agricultural Chemical Safety Assessments;Critical Reviews in Toxicology;2006-01

4. Toxicokinetics;Pharmacokinetics of Drugs;1994

5. Use of Toxicokinetic Principles in Drug Development: Bridging Preclinical and Clinical Studies;Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development;1993